Cargando…

“SARS-CoV-2 Infection in Liver Transplant Recipients - Immunosuppression is the Silver Lining?”

BACKGROUND: COVID-19 is associated with higher mortality among patients who have comorbidities. However, evidences related to COVID-19 among post liver transplant recipients are scarce and evolving. METHODS: Adult Indian patients who had undergone liver transplantation at our centre since 2006 and w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jadaun, Shekhar S., Singh, Shweta A., Madan, Kaushal, Gupta, Subhash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294560/ https://www.ncbi.nlm.nih.gov/pubmed/34305351 http://dx.doi.org/10.1016/j.jceh.2021.07.005

Ejemplares similares

Efficacy and safety of SARS-CoV-2 vaccines in living donor liver transplant recipients
por: Jadaun, Shekhar Singh, et al.
Publicado: (2022)

Post COVID-19 mucormycosis in liver transplant recipients-Walking on a tight rope
por: Jadaun, Shekhar Singh, et al.
Publicado: (2021)

“Strategies of liver transplantation during the second wave - based on lessons learnt from the first wave of the SARS- COV2 pandemic”
por: Singh, Shweta A., et al.
Publicado: (2021)

ABO incompatible living donor related liver transplant in COVID-19 pandemic: Challenges and outcomes
por: Jadaun, Shekhar Singh, et al.
Publicado: (2022)

Living donor liver transplant outcomes during the COVID-19 pandemic: does a decrease in case volume impact the overall outcomes?
por: Singh, Shweta A., et al.
Publicado: (2022)

Immunosuppression and SARS-CoV-2 Infection in Kidney Transplant Recipients
por: Devresse, Arnaud, et al.
Publicado: (2022)

Good outcomes of living donor liver transplant in primary sclerosing cholangitis: an experience from North India
por: Jadaun, Shekhar Singh, et al.
Publicado: (2022)

Determinants of Antibody Response to SARS-CoV-2 Vaccines in Liver Transplant Recipients: The Role of Immunosuppression Reduction
por: Cheng, Chih-Hsien, et al.
Publicado: (2022)

Correlation between thromboelastography and rotational thromboelastometry values in adult liver transplant recipients
por: Singh, Shweta A, et al.
Publicado: (2020)

Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients in Korea
por: Lee, Jee Hyun, et al.
Publicado: (2009)

Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients
por: Locke, Jayme E, et al.
Publicado: (2011)

Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma
por: Hussaarts, Koen G. A. M., et al.
Publicado: (2021)

Rapid Development of Syringocystadenocarcinoma Papilliferum in an Immunosuppressed Liver Transplant Recipient
por: Zilberg, Catherine, et al.
Publicado: (2022)

Antineoplastic chemotherapy and immunosuppression in liver transplant recipients: Squaring the circle?
por: Coupier, Antoine, et al.
Publicado: (2022)

Liver Injury at Presentation in COVID-19 is Associated with Immuno-Inflammatory Response
por: Bhargava, Richa, et al.
Publicado: (2022)

Humoral Response After SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Role of Immunosuppression Therapy
por: López, Verónica, et al.
Publicado: (2022)

Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients
por: Toniutto, Pierluigi, et al.
Publicado: (2022)

Efficacy and safety of SARS-CoV-2 vaccination in liver transplant recipients
por: Meunier, Lucy, et al.
Publicado: (2022)

Evaluation of Humoral Response following SARS-CoV-2 mRNA-Based Vaccination in Liver Transplant Recipients Receiving Tailored Immunosuppressive Therapy
por: Manzia, Tommaso Maria, et al.
Publicado: (2023)

Impact of immunosuppressant therapy on new-onset diabetes in liver transplant recipients
por: Liu, Fu-Chao, et al.
Publicado: (2017)

Immunosuppressive regimens on conversion of cytomegalovirus infection to disease in liver transplant recipients
por: Rabbani, Amirhassan, et al.
Publicado: (2022)

Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients
por: Rabinowich, Liane, et al.
Publicado: (2021)

SARS-CoV-2 infection in liver transplant recipients: A complex relationship
por: Alberca, Ricardo Wesley, et al.
Publicado: (2021)

Unexpectedly High Efficacy of SARS-CoV-2 BNT162b2 Vaccine in Liver versus Kidney Transplant Recipients—Is It Related to Immunosuppression Only?
por: Nazaruk, Paulina, et al.
Publicado: (2021)

Cirrhotic Liver of Liver Transplant Recipients Accumulate Silver and Co-Accumulate Copper
por: Poznański, Jarosław, et al.
Publicado: (2021)

The Impact of SARS-CoV-2 Infection, and Application of Immunosuppressive Agents in Kidney Transplant Recipients Suffering from COVID-19
por: Tseng, Horng-Ta, et al.
Publicado: (2021)

SARS-CoV-2 infection in heart transplant recipients: a systematic literature review of clinical outcomes and immunosuppression strategies
por: Ilonze, Onyedika J., et al.
Publicado: (2021)

SARS-CoV-2 hybrid immunity: silver bullet or silver lining?
por: Suryawanshi, Rahul, et al.
Publicado: (2022)

Curing Hepatitis C in Liver Transplant Recipients Is Associated with Changes in Immunosuppressant Use
por: Saab, Sammy, et al.
Publicado: (2016)

SARS-CoV-2 infection in liver transplant recipients: collaboration in the time of COVID-19
por: Heimbach, Julie K, et al.
Publicado: (2020)

Humoral Immune Response following SARS-CoV-2 Vaccination in Liver Transplant Recipients
por: Timmermann, Lea, et al.
Publicado: (2021)

Humoral response to different SARS-CoV-2 vaccines in orthotopic liver transplant recipients
por: Toapanta-Yanchapaxi, Liz, et al.
Publicado: (2022)

EXCELLENT ALLOGRAFT RECOVERY DESPITE PROLONGED SARS-COV-2 SHEDDING AFTER REDUCTION OF IMMUNOSUPPRESSION IN LUNG TRANSPLANT RECIPIENT
por: RAZIA, DEEPIKA, et al.
Publicado: (2021)

Critical Update on the Diagnosis and Management of COVID-19 in Advanced Cirrhosis and Liver Transplant Recipients
por: Philips, Cyriac Abby, et al.
Publicado: (2021)

Is the outcome of SARS-CoV-2 infection in solid organ transplant recipients really similar to that of the general population?
por: Mendoza, Maria A., et al.
Publicado: (2021)

SARS-CoV-2 Infection in the Heart Transplant Recipient
por: Shah, Jassim Zaheen, et al.
Publicado: (2020)

Tailored long-term immunosuppressive regimen for adult liver transplant recipients with hepatocellular carcinoma
por: Kang, Sung-Hwa, et al.
Publicado: (2014)

Real-World Multicenter Experience of Immunosuppression Minimization Among 661 Liver Transplant Recipients
por: Aguiar, Diego, et al.
Publicado: (2017)

Development of a predictive nomogram for switching immunosuppressive drugs in pediatric liver transplant recipients
por: Gu, Guangxiang, et al.
Publicado: (2023)

Malpositioning of pulmonary artery catheter into the inferior vena cava in a liver transplant recipient
por: Singh, Shweta A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4cjonti8s246jfm6ippggdpumh